文献速递肿瘤 PET/CT

深度学习特征揭示复发鼻咽癌与生物学功能及生存相关的多尺度瘤内异质性

Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-04-26

研究回顾性纳入420例复发鼻咽癌(rNPC)患者,利用PET/CT影像构建多模态深度学习特征并建立整合列线图。整合列线图在训练集和测试集的C指数分别为0.741和0.732,可将患者分为高、低风险组(训练集HR 4.56,测试集HR 4.05,均p<0.001)。亚组分析显示低风险患者可从手术和再放疗中获益,而高风险与低风险组接受化疗的生存率无差异。

要点

  • 基于PET/CT的深度学习特征在复发鼻咽癌中显示出令人满意的预后预测性能。
  • 整合年龄、rT分期和PET/CT深度学习特征的列线图可将患者分为高、低风险组。
  • 低风险患者被认为应接受手术和再放疗,高风险患者姑息性化疗可能足够。

核心结论

  • 基于PET/CT的深度学习特征在复发鼻咽癌患者中显示出令人满意的预后预测性能。
  • 整合深度学习特征的列线图成功将患者分为不同风险组,并具有指导个体化治疗的较大潜力:低风险患者被认为应接受手术和再放疗,而高风险患者姑息性化疗可能足够。

研究设计与样本

  • 回顾性纳入420例具有PET/CT影像和总生存(OS)随访的复发鼻咽癌患者。
  • 所有患者按6:4比例随机分为训练集(n=269)和测试集(n=151)。
  • 使用轻量级深度卷积神经网络EfficienetNet-lite0和生存损失DeepSurvLoss从PET和CT图像构建多模态深度学习特征。
  • 构建整合临床因素和PET/CT深度学习特征的整合列线图,并建立临床列线图和单模态深度学习列线图用于比较。
  • 通过RNA测序(RNA-seq)分析整合列线图产生的生存风险与生物学功能之间的关联。

主要发现

  • 整合年龄、rT分期和深度学习PET/CT特征的整合列线图C指数在训练集为0.741(95%CI:0.688-0.794),在测试集为0.732(95%CI:0.679-0.785)。
  • 列线图在训练集和测试集中均将患者分为高风险和低风险两组,风险比(HR)分别为4.56(95%CI:2.80-7.42,p<0.001)和4.05(95%CI:2.21-7.43,p<0.001)。
  • 整合列线图的C指数显著高于临床列线图和单模态列线图。
  • 按性别、N分期或EBV DNA分层时,整合列线图的风险预测在所有患者亚组中均有效。
  • 进一步亚组分析显示,低风险患者可从手术和再放疗中获益,而高风险与低风险组接受化疗的患者生存率无差异。

关键数值与推荐

  • 整合列线图C指数在训练集为0.741(95%CI:0.688-0.794),在测试集为0.732(95%CI:0.679-0.785)。
  • 训练集高风险与低风险组HR为4.56(95%CI:2.80-7.42,p<0.001)。
  • 测试集高风险与低风险组HR为4.05(95%CI:2.21-7.43,p<0.001)。

临床怎么用

  • 作者认为,低风险患者应接受手术和再放疗,而高风险患者姑息性化疗可能足够。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: How to discriminate different risks of recurrent nasopharyngeal carcinoma (rNPC) patients and guide individual treatment has become of great importance. This study aimed to explore the associations between deep learning signatures and biological functions as well as survival in (rNPC) patients. METHODS: A total of 420 rNPC patients with PET/CT imaging and follow-up of overall survival (OS) were retrospectively enrolled. All patients were randomly divided into a training set (n = 269) and test set (n = 151) with a 6:4 ratio. We constructed multi-modality deep learning signatures from PET and CT images with a light-weighted deep convolutional neural network EfficienetNet-lite0 and survival loss DeepSurvLoss. An integrated nomogram was constructed incorporating clinical factors and deep learning signatures from PET/CT. Clinical nomogram and single-modality deep learning nomograms were also built for comparison. Furthermore, the association between biological functions and survival risks generated from an integrated nomogram was analyzed by RNA sequencing (RNA-seq). RESULTS: The C-index of the integrated nomogram incorporating age, rT-stage, and deep learning PET/CT signature was 0.741 (95% CI: 0.688-0.794) in the training set and 0.732 (95% CI: 0.679-0.785) in the test set. The nomogram stratified patients into two groups with high risk and low risk in both the training set and test set with hazard ratios (HR) of 4.56 (95% CI: 2.80-7.42, p < 0.001) and 4.05 (95% CI: 2.21-7.43, p < 0.001), respectively. The C-index of the integrated nomogram was significantly higher than the clinical nomogram and single-modality nomograms. When stratified by sex, N-stage, or EBV DNA, risk prediction of our integrated nomogram was valid in all patient subgroups. Further subgroup analysis showed that patients with a low-risk could benefit from surgery and re-irradiation, while there was no difference in survival rates between patients treated by chemotherapy in the high-risk and low-risk groups. RNA sequencing (RNA-seq) of data further explored the mechanism of high- and low-risk patients from the genetic and molecular level. CONCLUSION: Our study demonstrated that PET/CT-based deep learning signatures showed satisfactory prognostic predictive performance in rNPC patients. The nomogram incorporating deep learning signatures successfully divided patients into different risks and had great potential to guide individual treatment: patients with a low-risk were supposed to be treated with surgery and re-irradiation, while for high-risk patients, the application of palliative chemotherapy may be sufficient.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Zhao X, Liang YJ, Zhang X, et al. Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2022. PMID: 35471254. doi:10.1007/s00259-022-05793-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。